increased pituitary adenoma incidence_Drd2<tm1Ebo>/Drd2<tm1Ebo>

http://metadb.riken.jp/0002041I129S2SvPasC57BL6Drd2tm1EboDrd2tm1EboDrd2tm1Ebo

increased pituitary adenoma incidence_Drd2<tm1Ebo>/Drd2<tm1Ebo>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• dopamine receptor D2
  http://metadb.riken.jp/db/mgi_rdf/MGI:94924

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Drd2<tm1Ebo>/Drd2<tm1Ebo>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Drd2<tm1Ebo>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S2/SvPas * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased pituitary adenoma incidence
  http://purl.obolibrary.org/obo/MP_0002041

文献

http://purl.org/net/cito/citesAsAuthority

• A. Saiardi, et.al., Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia., Neuron, 1997, 19
  http://rdf.ncbi.nlm.nih.gov/pubmed/9247268